Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 4—April 2023
CME ACTIVITY - Synopsis

Pediatric Invasive Meningococcal Disease, Auckland, New Zealand (Aotearoa), 2004–2020

Cameron BurtonComments to Author , Emma Best, Matthew Broom, Helen Heffernan, Simon Briggs, and Rachel Webb
Author affiliations: The University of Auckland, Auckland, New Zealand (C. Burton, E. Best, R. Webb); Te Whatu Ora Counties Manukau, Auckland (C. Burton, R. Webb); Te Whatu Ora Te Toka Tumai Auckland, Auckland (E. Best, S. Briggs, R. Webb); Te Whatu Ora Waitematā, Auckland (M. Broom); Institute of Environmental Science and Research, Wellington, New Zealand (H. Heffernan).

Main Article

Figure 1

Timeline of 319 cases of confirmed invasive meningococcal disease in children <15 year of age, by serogroup, reported by year, Auckland, New Zealand, 2004–2020. Numbers along data line indicate exact rates for all cases by year. Men, Neisseria meningitidis serogroup.

Figure 1. Timeline of 319 cases of confirmed invasive meningococcal disease in children <15 year of age, by serogroup, reported by year, Auckland, New Zealand, 2004–2020. Numbers along data line indicate exact rates for all cases by year. Men, Neisseria meningitidis serogroup.

Main Article

Page created: February 01, 2023
Page updated: March 16, 2023
Page reviewed: March 16, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external